跳转至内容
Merck
CN

651419

富马酸单甲酯

97%

别名:

反丁烯二酸一甲酯, 富马酸单甲基酯

登录 查看组织和合同定价。

选择尺寸


关于此项目

线性分子式:
HO2CCH=CHCO2CH3
化学文摘社编号:
分子量:
130.10
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
220-412-6
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

富马酸单甲酯, 97%

InChI key

NKHAVTQWNUWKEO-NSCUHMNNSA-N

InChI

1S/C5H6O4/c1-9-5(8)3-2-4(6)7/h2-3H,1H3,(H,6,7)/b3-2+

SMILES string

COC(=O)\C=C\C(O)=O

assay

97%

form

solid

mp

144-145 °C (lit.)

functional group

carboxylic acid
ester

Quality Level

正在寻找类似产品? 访问 产品对比指南

Application

富马酸单甲酯可作为反应物合成:含
  • Jumonji C 结构域的组蛋白去甲基化酶 (JCHDMs) 抑制剂。
  • (-)-木糖酰胺 A,一种真菌代谢产物。
  • (±)-甲氧基伏米霉素乙酯,一种潜在的细菌肽脱甲酰基酶抑制剂。

它也是一种广谱抗菌剂,具有强大的抗氧化活性。

pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Eye Irrit. 2

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

A concise synthesis of (?)-methoxyfumimycin ethyl ester.
Zhou Z, et al.
J. Chem. Res. (M), 38(6) (2014)
Jennifer N Hahn et al.
Journal of immunology (Baltimore, Md. : 1950), 197(10), 3850-3860 (2016-10-14)
Extracellular matrix metalloproteinase inducer (EMMPRIN, CD147) is a transmembrane glycoprotein that is upregulated on leukocytes in active lesions in multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). Administration of anti-EMMPRIN Abs reduces the severity of EAE. Minocycline
A selective inhibitor and probe of the cellular functions of Jumonji C domain-containing histone demethylases.
Luo X, et al.
Journal of the American Chemical Society, 133(24), 9451-9456 (2011)
Isolation and structure elucidation of the new fungal metabolite (−)-xylariamide A.
Davis R A, et al.
Journal of Natural Products, 68(5), 769-772 (2005)
Laura Northrup et al.
Molecular pharmaceutics, 14(1), 66-80 (2017-01-04)
Current therapies to treat autoimmune diseases often result in side effects such as nonspecific immunosuppression. Therapies that can induce antigen-specific immune tolerance provide an opportunity to reverse autoimmunity and mitigate the risks associated with global immunosuppression. In an effort to

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持